Abnormal chromosome migration and chromosome aberrations in mouse oocytes during meiosis II in the presence of topoisomerase II inhibitor ICRF-193

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 502, Issue 1-2, 2002, Pages 1-9

  Tateno, Hiroyuki ^a   Kamiguchi, Yujiroh ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Chromosome aberrations; ICRF 193; Meiosis II; Mouse oocytes; Topoisomerase II inhibitor

Indexed keywords

2,3 BIS(3,5 DIOXO 1 PIPERAZINYL)BUTANE; GYRASE INHIBITOR;

ANAPHASE; ANEUPLOIDY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CYCLE S PHASE; CELL DIVISION; CENTROMERE; CHROMATID; CHROMOSOME ABERRATION; CHROMOSOME STRUCTURE; CONTROLLED STUDY; EGG; FEMALE; MEIOSIS; METAPHASE; MOUSE; NONHUMAN; OOCYTE; PARTHENOGENESIS; PRIORITY JOURNAL; PRONUCLEUS; TELOPHASE;

ANIMALS; CHROMOSOME ABERRATIONS; DNA REPLICATION; DNA TOPOISOMERASES, TYPE II; ENZYME INHIBITORS; KARYOTYPING; MEIOSIS; MICE; OOCYTES; PIPERAZINES;

EID: 0037157226     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(02)00021-0     Document Type: Article

References (31)

1. The roles of DNA topoisomerase II during the cell cycle
2. DNA topoisomerases
3. Preferential pericentric lesions and aneuploidy induced in mouse oocytes by topoisomerase II inhibitor etoposide
4. Numerical and structural chromosome aberrations induced by etoposide (VP-16) during oocyte maturation of mice: Transmission to 1-cell zygotes and damage to dictyate oocytes
5. Meiotic stage-dependent induction of chromosome aberrations in Chinese hamster primary oocytes exposed to topoisomerase II inhibitor etoposide
6. Fragmentation of centromeric DNA and prevention of homologous chromosome separation in male meiosis in vivo by the topoisomerase II inhibitor etoposide
7. Etoposide induces heritable chromosomal aberrations and aneuploidy during male meiosis in the mouse
8. Effects of the DNA topoisomerase II inhibitor merbarone in male mouse meiotic divisions in vivo: Cell cycle arrest and induction of aneuploidy
9. An improved culture medium supports development of random-bred 1-cell mouse embryos in vitro
10. Strontium supports capacitation and the acrosome reaction in mouse sperm and rapidly activates mouse eggs
11. Developmental potential and chromosome constitution of strontium-induced mouse parthenogenones
12. A new assessment system for chromosomal mutagenicity using oocytes and early zygotes of the Chinese hamster
13. DNA replication in the 1-cell mouse embryo: Stimulatory effect of histone acetylation
14. A simple technique for demonstrating centromeric heterochromatin
15. Inhibitors of DNA topoisomerase II prevent chromatid separation in mammalian cells but do not prevent exit from mitosis
16. Inhibitors of topoisomerases do not block the passage of human lymphocyte chromosomes through mitosis
17. Inhibitors of topoisomerase II delay progress through mitosis and induce a doubling of the DNA content in CHO cells
18. Topoisomerase II inhibition prevents anaphase chromatid segregation in mammalian cells independently of the generation of DNA strand breaks
19. Cell cycle progression and chromosome segregation in mammalian cells cultured in the presence of the topoisomerase II inhibitors ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane; ADR-529] and ICRF-159 (Razoxane)
20. Inhibition of DNA topoisomerase II by ICRF-193 induces polyploidization by uncoupling chromosome dynamics from other cell cycle events
21. 2 arrest by DNA topoisomerase II inhibitors merbarone and VM-26
22. Cytogenetic evaluation of the mechanism of cell death induced by the novel anthracenyl-amino acid topoisomerase II catalytic inhibitor NU/ICRF 500
23. Topoisomerase II inhibition in mitosis produces numerical and structural chromosomal aberrations in human fibroblasts
24. Mutagenicity and carcinogenicity of topoisomerase-interactive agents
25. Induction of chromosomal aberrations (unstable and stable) by inhibitors of topoisomerase II, m-AMSA and VP-16, using conventional Giemsa staining and chromosome painting techniques
26. In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone
27. Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: Mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors
28. Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives
29. Effects of an inhibitor of topoisomerase II, ICRF-193 on the formation of ultraviolet-induced chromosome aberrations
30. Hypothesis: Some mutagens directly alter specific chromosomal proteins (DNA topoisomerase II and peripheral proteins) to produce chromosome stickiness, which causes chromosome aberrations